| Financial Year |
March 31 2023 |
| Monetary Funds |
396,713,369.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
446,323,661.48 |
| Advances to Suppliers |
13,239,885.27 |
| Other Receivables |
4,109,984.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
908,852,556.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
128,817,131.04 |
| Total Current Assets |
1,943,907,962.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,245,830.78 |
| Investment Properties |
6,025,944.63 |
| Fixed Assetes |
3,013,087,577.03 |
| Under-construction Projects |
435,557,113.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
141,822,742.34 |
| R&D expenses |
-- |
| Goodwill |
30,876,149.40 |
| Long-Term Deferred and Prepaid Expenses |
7,038,901.78 |
| Deferred Income Tax Assets |
15,894,924.01 |
| Other Non-Current Assets |
8,766,449.39 |
| Sub-Total of Non-Current Assets |
3,668,405,812.58 |
| Total Assets |
5,612,313,775.20 |
| Short-Term Loans |
477,419,902.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
223,206,253.67 |
| Accounts Payable |
452,212,725.29 |
| Accounts Received In Advance |
259,938.82 |
| Employee Compensation Payable |
28,902,991.41 |
| Taxes Payable |
27,297,243.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,197,809.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
459,124,375.47 |
| Other Current Liabilities |
1,119,211.50 |
| Sub-Total of Current Liabilities |
1,709,081,998.38 |
| Long-term Loans |
450,396,981.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
34,043,002.40 |
| Deferred Income Tax Liabilities |
37,758,619.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
557,888,407.30 |
| Total Liabilities |
2,266,970,405.68 |
| Paid-In Capital(Or Share Stock) |
1,062,912,523.00 |
| Capital Surplus |
1,333,454,170.82 |
| Surplus Reserve |
113,312,114.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
891,625,860.58 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,345,343,369.52 |
| Owner's Equity（Stockholder's Equity） |
3,345,343,369.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,612,313,775.20 |
